ATP stimulates human placental 11β-hydroxysteroid dehydrogenase type 2 activity by a novel mechanism independent of phosphorylation
✍ Scribed by K. Yang; D.B. Hardy; M.A. Doumouras; J.P. van Beek; E. Rocha
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 136 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The human placental 11β‐hydroxysteroid dehydrogenase type 2 (11β‐HSD2) is believed to play a key role in fetal development since this enzyme protects the fetus from exposure to high levels of maternal cortisol by virtue of converting maternal cortisol to its inert metabolite cortisone. The present study was undertaken to examine the effect of ATP on 11β‐HSD2 activity in human placental microsomes. Enzyme activity, reflected by the rate of conversion of cortisol to cortisone, was stimulated more than six‐fold by 0.5 mM ATP (EC~50~ = 0.2 mM). Such stimulation appears to be mediated through a novel mechanism independent of ATP‐induced phosphorylation of the reaction components since AMP‐PNP, a non‐hydrolyzable analogue of ATP, was equally effective. The ATP‐induced stimulation of 11β‐HSD2 activity is adenine nucleotide specific in that a similar stimulation was observed with ADP and AMP but not with CTP, GTP, or UTP. Furthermore, ATP increased the maximal velocity (V~max~) of the 11β‐HSD2 catalyzed conversion of cortisol to cortisone without altering the apparent K~m~ of 11β‐HSD2 for cortisol, suggesting that ATP may stimulate enzyme activity by interacting with the enzyme at a site other than that involved in substrate binding. In conclusion, the present study has identified ATP as a novel regulator of human placental 11β‐HSD2 in vitro. It is conceivable that intracellular ATP may have a profound effect on 11β‐HSD2 function in vivo. J. Cell. Biochem. 84: 295–300, 2002. © 2001 Wiley‐Liss, Inc.